Clinical trial
Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal…
NCT00254267 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00254267 |
|---|---|
| Title | Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors |
| Official title | An Open-label Phase 2 Study of AMG 706 in Japanese Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) Who Developed Progressive Disease or Relapsed While on Imatinib Mesylate |
| Lead sponsor | Amgen, Industry |
| Collaborators | Takeda Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Gastrointestinal Stromal Tumor |
| Intervention type | Drug |
| Interventions | AMG 706 |
| Enrollment | 35 |
| Start date | Nov 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Dec 1, 2012 |
| First posted | Nov 16, 2005 |
| Last update posted | Feb 27, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: